BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 27, 2018
View Archived Issues
Dyanavel XR pharmacokinetics studied in younger pediatric population
Read More
Promising effects observed with JNJ-54175446 in major depressive disorder
Read More
UCM-924, a melatonin MT2 receptor agonist, shows promise for treating neuropathic pain
Read More
Portola Pharmaceuticals presents phase II data for cerdulatinib in patients with T-cell lymphoma
Read More
Cysteine protease ATG4B inhibitor LV-320 targets autophagy in leukemic cells
Read More
Researchers present new gene therapy for sickle cell anemia
Read More
Identification and evaluation of novel dual inhibitors of sodium-dependent glucose cotransporters
Read More
Otsuka opens enrollment in phase III trial of OPC-61815 for congestive heart failure
Read More
Momenta initiates phase II trial of M-281 in generalized myasthenia gravis
Read More
Alnylam Pharmaceuticals develops siRNA targeting the thrombopoietin gene in the liver
Read More
Novel CD38 CAR cell therapy for the treatment of multiple myeloma
Read More
Tumor-targeted trimeric 4-1BB-agonistic antibody 1D8N/CEGa1 shows safety and efficacy in vivo
Read More
ASO for LCA
Read More
New LAG-3 ligand identified
Read More
Oryzon patents lysine-specific demethylase inhibitors
Read More
NantBioScience reports high-affinity nerve growth factor receptor inhibitors
Read More
Shenzhen Salubris Pharmaceuticals describes DPP-IV inhibitors for diabetes
Read More
MEI Pharma initiates phase II study of ME-401 in follicular lymphoma
Read More
TRACON Pharmaceuticals submits IND application for TJ-4309
Read More
Mitophagy findings may offer new PD treatment promise
Read More
AbbVie licenses Lupin's MALT1 inhibitor program
Read More
Positive data presented from dose-escalation portion of phase I study of TRC-105
Read More
Sunshine Lake Pharma reports agents for the treatment of HBV infections
Read More
ROMK inhibitors reported in Bristol-Myers Squibb patent
Read More
Tyvyt approved in China for the treatment of Hodgkin's lymphoma
Read More
Capricor places voluntary hold on phase II HOPE-2 study of CAP-1002
Read More
FDA approves pediatric hexavalent combination vaccine Vaxelis
Read More
Arrowhead Pharmaceuticals initiates phase I study of ARO-ANG3
Read More
